Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-16
DOI
10.1038/s41598-020-79125-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle
- (2020) Chao Zhang et al. International Journal of Nanomedicine
- Multiplexed mRNA Sensing and Combinatorial-Targeted Drug Delivery Using DNA-Gold Nanoparticle Dimers
- (2018) Maria-Eleni Kyriazi et al. ACS Nano
- Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models
- (2018) Maofan Zhang et al. BIOMATERIALS
- Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages
- (2018) Sofia Raniolo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells
- (2018) Fiorella Vanderhoeven et al. Oncotarget
- Multifunctional trastuzumab–chlorin e6 conjugate for the treatment of HER2-positive human breast cancer
- (2018) Kyoung Sub Kim et al. Biomaterials Science
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA-based nanoscaffolds as vehicles for 5-fluoro-2′-deoxyuridine oligomers in colorectal cancer therapy
- (2018) A. F. Jorge et al. Nanoscale
- DNA-doxorubicin interaction: New insights and peculiarities
- (2016) E. F. Silva et al. BIOPOLYMERS
- The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence
- (2016) William H Gmeiner et al. Future Oncology
- Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors
- (2016) Javad Akhtari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells
- (2016) Aili Suo et al. Materials Science & Engineering C-Materials for Biological Applications
- iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy
- (2016) Jinming Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- New Developments in Liposomal Drug Delivery
- (2015) Bhushan S. Pattni et al. CHEMICAL REVIEWS
- Systematic discovery of drug interaction mechanisms
- (2015) G. Chevereau et al. Molecular Systems Biology
- Cocoon-Like Self-Degradable DNA Nanoclew for Anticancer Drug Delivery
- (2014) Wujin Sun et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Spherical Nucleic Acids
- (2012) Joshua I. Cutler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Engineering DNA-based functional materials
- (2011) Young Hoon Roh et al. CHEMICAL SOCIETY REVIEWS
- PEGylated Anti-MUC1 Aptamer-Doxorubicin Complex for Targeted Drug Delivery to MCF7 Breast Cancer Cells
- (2011) Lihan Tan et al. MACROMOLECULAR BIOSCIENCE
- Cellular Response of Polyvalent Oligonucleotide−Gold Nanoparticle Conjugates
- (2010) Matthew D. Massich et al. ACS Nano
- Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells
- (2010) Takuya Shishido et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Progression and treatment of HER2-positive breast cancer
- (2009) April Davoli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Affitoxin—A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors
- (2009) Rafal Zielinski et al. JOURNAL OF IMMUNOTHERAPY
- Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers
- (2009) Santosh Aryal et al. JOURNAL OF MATERIALS CHEMISTRY
- Regulating Immune Response Using Polyvalent Nucleic Acid−Gold Nanoparticle Conjugates
- (2009) Matthew D. Massich et al. MOLECULAR PHARMACEUTICS
- Mechanisms of drug combinations: interaction and network perspectives
- (2009) Jia Jia et al. NATURE REVIEWS DRUG DISCOVERY
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
- (2008) Andrew D. Seidman et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2-Specific Affibody-Conjugated Thermosensitive Liposomes (Affisomes) for Improved Delivery of Anticancer Agents
- (2008) Anu Puri et al. JOURNAL OF LIPOSOME RESEARCH
- Polyvalent DNA Nanoparticle Conjugates Stabilize Nucleic Acids
- (2008) Dwight S. Seferos et al. NANO LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now